share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

诺瓦瓦克斯医药 | 4:持股变动声明-董事 YOUNG JAMES F
美股SEC公告 ·  06/26 04:18

Moomoo AI 已提取核心信息

James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
诺瓦瓦克斯医药公司[NVAX]的詹姆斯·F·扬在2024年6月21日完成了对7500股普通股的出售。这笔交易在公开市场上进行,每股售价为14.09美元,总售价为105,675美元。销售后,扬在诺瓦瓦克斯普通股中的直接持股数量为61,760股。
诺瓦瓦克斯医药公司[NVAX]的詹姆斯·F·扬在2024年6月21日完成了对7500股普通股的出售。这笔交易在公开市场上进行,每股售价为14.09美元,总售价为105,675美元。销售后,扬在诺瓦瓦克斯普通股中的直接持股数量为61,760股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息